Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Full agenda for next week's Oncologic Drugs Advisory Committee meeting

Sep. 9, 1999

Topoisomerase poisons emerge from research at U.S. university

Sep. 9, 1999

RPR reports new naphthyl-piperazinone antitumor agents

Sep. 9, 1999

Kirin Brewery reports SAR in the area of Fas/FAP-1 binding inhibitors

Sep. 8, 1999

Onyx to initiate phase III trial with ONYX-015 in treatment of head and neck cancer

Sep. 8, 1999

Antiproliferative agents and protein farnesyltransferase inhibitors designed at RPR

Sep. 8, 1999

Licensing opportunity from NIH: novel acyltriazene antitumor agents

Sep. 8, 1999

Cyclic peptide represents new lead for tumor-targeting anticancer therapies

Sep. 7, 1999

Schering-Plough and British Biotech to develop MMPIs for treatment of cancer

Sep. 7, 1999

UroGenesys announces U.S. patent for PSA promoter sequences

Sep. 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...